📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! Tell us what works, what doesn't, and how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community. Please send your feedback to gateway@ukri.org by 11 August 2025.

A multicentre randomiSed controlled TRial of IntraVEnous immunoglobulin compared with standard therapy for the treatment of transverse myelitis in adults and children (STRIVE). (2017)

First Author: Absoud M

Attributed to: MRC Centre for Neuropsychiatric Genetics and Genomics funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3310/hta21310

PubMed Identifier: 28639937

Publication URI: http://europepmc.org/abstract/MED/28639937

Type: Journal Article/Review

Volume: 21

Parent Publication: Health technology assessment (Winchester, England)

Issue: 31

ISSN: 1366-5278